Inhalation Research Services
Efficacy studies/ Disease models
Formulation
PK studies
Aerosol characterization
In vivo
PK studies
Ex vivo
Isolated Perfused Lung method
In vitro
dissolution tests – Dissolv
It
In vitro
cell permeability tests
Toxicology studies
Combination product development/ Device selection/ CMC data
Instruments
PreciseInhale
®
Precision dosing
PreciseInhale
®
input: Inhaler
PreciseInhale
®
input: Nebulizer
Dissolv
It
®
Xpose
ALI
®
Nose-Only
Intratracheal
Technical specifications
Publications
White paper
Webinars
About
About Us
Our Customers
Our Team
Management
Board
Advisory Board
Investors / investerare
Bolagsanalys
Pressmeddelanden
Prenumerera
IPO 2017
Finansiering
Finansiella rapporter
Kalender
Ägarlista
Bolagstämma
Bolagsstyrning
Presentationer
Contact
Category "PreciseInhale® – in vivo exposure"
Categories
Okategoriserade
PreciseInhale® – in vivo exposure
PreciseInhale® – Isolated Perfused Lung (IPL)
PreciesInhale® – Clinic
DissolvIt® – Dissolution tests
XposeALI® – Cell culture exposure
Archive
september 2022
maj 2022
april 2022
mars 2022
februari 2022
november 2021
juni 2021
mars 2021
december 2020
juni 2020
mars 2020
december 2019
Contact us!
